A Neuralink rival wants to give people who can't talk their voices back with a high-tech brain chipByBruce GilPublishedJuly 28, 2024
Boomers and millennials are spending extra vacation days on cruises, says Royal Caribbean CEOByBruce GilPublishedJuly 26, 2024
An Ozempic rival is getting closer to market — and it's hurting Novo Nordisk and Eli Lilly stockByBruce GilPublishedJuly 25, 2024
Rupert Murdoch is fighting with his kids over the future of his media empireByBruce GilUpdatedJuly 25, 2024
Amazon Prime Video is getting a new look — and it's designed for indecisive usersByBruce GilUpdatedJuly 24, 2024
Google is using the Paris Olympics to showcase its Gemini AI. Here's howByBruce GilPublishedJuly 24, 2024
Drug middlemen are pushing patients to pay for more expensive drugs, lawmakers findByBruce GilPublishedJuly 23, 2024
More people without diabetes are using weight loss drugs like Ozempic, study saysByBruce GilPublishedJuly 23, 2024
Hims & Hers has a 'long future' in selling off-brand Ozempic, former Novo Nordisk executive saysByBruce GilPublishedJuly 22, 2024
Lawmakers propose healthcare cybersecurity bill to tackle growing threatsByBruce GilPublishedJuly 19, 2024
The CrowdStrike global tech outage hit hospitals around the world and delayed surgeriesByBruce GilPublishedJuly 19, 2024
The CrowdStrike global tech outage took news outlets off the air for hoursByBruce GilUpdatedJuly 19, 2024
